Use specification
Intended users, patient groups, use environments, operating principle, user profiles, training assumptions and foreseeable use conditions.
Human Factors & Usability
We support proportionate usability engineering for SaMD and software-enabled devices, from use specification and risk analysis through study planning, documentation and regulatory integration.
Selected clients
Healthcare teams we have supported


















Scope and deliverables
Capability is defined by the agreed project team. Where independent moderators, representative-user recruitment, specialized facilities or additional human-factors expertise are needed, those roles are identified rather than implied.
Intended users, patient groups, use environments, operating principle, user profiles, training assumptions and foreseeable use conditions.
User workflows, task decomposition, interface boundaries, information flow and identification of tasks with potential safety consequences.
Use errors, close calls, foreseeable misuse, hazardous scenarios, critical tasks and links to ISO 14971 risk controls.
Learning objectives, participant profiles, scenarios, moderation approach, observations and iterative design feedback.
Representative-user groups, critical-task scenarios, training decay, acceptance rationale, data capture and analysis planning.
Usability engineering file structure, FDA submission narrative or EU technical-documentation inputs, findings and residual-risk rationale.
Ways to work together
Assess existing design and risk records against the pathway and identify the work still needed.
Develop use specification, analyses, protocols and reports with agreed specialist and sponsor inputs.
Trace an authority question to the underlying design, study or documentation gap and structure the response.
How it works
Define users, tasks, environments, training, interfaces and safety context.
Identify critical tasks and connect use errors to hazardous situations and controls.
Plan proportionate formative and, where required, validation work with qualified roles.
Consolidate methods, results, design actions, residual risk and submission evidence.
Regulations, standards and guidance considered
Frequently asked questions
No. User experience can address satisfaction and convenience; regulatory usability engineering focuses on safety-related interface characteristics, foreseeable use errors and evidence that risk controls support safe and effective use.
FDA expects the need and scope to follow from use-related risk. Validation is generally important when critical tasks remain and the user interface is relied on to control serious use-related harm. Product-specific FDA guidance and feedback may alter expectations.
There is no universal number for every study. FDA often discusses at least 15 participants per distinct user population for many validation studies, but the correct design depends on user groups, risk, device, tasks and current guidance. A number alone does not make a study adequate.
Usually not for validation if their product knowledge, training or professional background differs from intended users. Representativeness should cover relevant characteristics, experience and use conditions, with exclusions justified.
Those capabilities are not assumed. We define the required participant, moderation and environment specifications and agree whether the sponsor or qualified external providers will supply recruitment, facilities or independent specialist services.
No. Authorities assess whether methods, representativeness, critical-task coverage and conclusions are adequate. Early planning and traceability reduce avoidable gaps but do not guarantee a decision.
Start with the product you have